Gallagher Capital Advisors LLC Purchases Shares of 5,154 Intuitive Surgical, Inc. (NASDAQ:ISRG)

Gallagher Capital Advisors LLC bought a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 5,154 shares of the medical equipment provider's stock, valued at approximately $2,690,000. Intuitive Surgical comprises 2.0% of Gallagher Capital Advisors LLC's investment portfolio, making the stock its 19th largest position.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Moran Wealth Management LLC lifted its position in shares of Intuitive Surgical by 1.7% in the 4th quarter. Moran Wealth Management LLC now owns 1,778 shares of the medical equipment provider's stock valued at $928,000 after acquiring an additional 29 shares in the last quarter. Main Street Research LLC lifted its position in shares of Intuitive Surgical by 1.9% in the 4th quarter. Main Street Research LLC now owns 79,531 shares of the medical equipment provider's stock valued at $41,512,000 after acquiring an additional 1,482 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of Intuitive Surgical by 24.5% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 187,398 shares of the medical equipment provider's stock valued at $97,814,000 after acquiring an additional 36,865 shares in the last quarter. NBT Bank N A NY lifted its position in shares of Intuitive Surgical by 28.0% in the 4th quarter. NBT Bank N A NY now owns 2,489 shares of the medical equipment provider's stock valued at $1,299,000 after acquiring an additional 544 shares in the last quarter. Finally, Taika Capital LP purchased a new stake in shares of Intuitive Surgical in the 4th quarter valued at approximately $4,685,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Remove Ads

Intuitive Surgical Price Performance

NASDAQ:ISRG traded up $3.58 during midday trading on Wednesday, reaching $497.30. The stock had a trading volume of 2,557,102 shares, compared to its average volume of 1,425,013. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The firm's fifty day simple moving average is $569.42 and its 200-day simple moving average is $531.60. The stock has a market capitalization of $177.13 billion, a P/E ratio of 77.58, a PEG ratio of 5.85 and a beta of 1.43.

Insider Activity at Intuitive Surgical

In related news, CFO Jamie Samath sold 269 shares of the firm's stock in a transaction on Monday, February 10th. The shares were sold at an average price of $590.00, for a total value of $158,710.00. Following the transaction, the chief financial officer now directly owns 3,282 shares in the company, valued at approximately $1,936,380. This trade represents a 7.58 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, EVP Brian Edward Miller sold 8,900 shares of the stock in a transaction on Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the completion of the sale, the executive vice president now directly owns 5,758 shares of the company's stock, valued at approximately $2,793,033.06. This trade represents a 60.72 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 22,209 shares of company stock worth $11,928,127. 0.90% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on ISRG shares. Barclays upped their price target on shares of Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. Erste Group Bank upgraded shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Tuesday, November 19th. CICC Research began coverage on shares of Intuitive Surgical in a research note on Monday, January 27th. They issued a "neutral" rating and a $550.00 price objective on the stock. Evercore ISI upped their price objective on shares of Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Finally, Piper Sandler reiterated an "overweight" rating and issued a $670.00 price objective (up previously from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. One analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.